Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases
SAN CARLOS, Calif.--(BUSINESS WIRE)--Siolta Therapeutics, a clinical-stage biotech company, announced today it has raised $30M in a series B investment...